Upgrade to SI Premium - Free Trial

Navidea Biopharma (NAVB) Appoints Dr. Michael Rosol as CMO

November 29, 2018 4:31 PM
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) , a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Comments

Next Articles